Lord, Abbett & Co’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.29M | Sell |
8,726
-3,091
| -26% | -$1.68M | 0.01% | 481 |
|
|
2025
Q4 | $6.85M | Buy |
+11,817
| New | +$6.68M | 0.02% | 427 |
|
|
2025
Q3 | – | Sell |
-71,870
| Closed | -$29.1M | – | 580 |
|
|
2025
Q2 | $29.1M | Buy |
71,870
+606
| +0.9% | +$253K | 0.09% | 233 |
|
|
2025
Q1 | $35.5M | Sell |
71,264
-3,517
| -5% | -$1.9M | 0.13% | 202 |
|
|
2024
Q4 | $38.9M | Sell |
74,781
-2,496
| -3% | -$1.37M | 0.12% | 210 |
|
|
2024
Q3 | $47.8M | Sell |
77,277
-2,758
| -3% | -$1.63M | 0.15% | 182 |
|
|
2024
Q2 | $44.3M | Buy |
80,035
+1,788
| +2% | +$1.02M | 0.14% | 184 |
|
|
2024
Q1 | $45.5M | Buy |
78,247
+1,480
| +2% | +$830K | 0.15% | 190 |
|
|
2023
Q4 | $40.7M | Buy |
76,767
+2,423
| +3% | +$1.17M | 0.14% | 197 |
|
|
2023
Q3 | $37.6M | Sell |
74,344
-2,450
| -3% | -$1.31M | 0.14% | 209 |
|
|
2023
Q2 | $40.1M | Sell |
76,794
-737
| -1% | -$398K | 0.14% | 212 |
|
|
2023
Q1 | $44.7M | Sell |
77,531
-3,449
| -4% | -$1.94M | 0.16% | 202 |
|
|
2022
Q4 | $44.6M | Sell |
80,980
-121,258
| -60% | -$64.3M | 0.16% | 191 |
|
|
2022
Q3 | $103M | Buy |
202,238
+46,169
| +30% | +$25.8M | 0.37% | 70 |
|
|
2022
Q2 | $84.8M | Sell |
156,069
-71,714
| -31% | -$39.5M | 0.3% | 93 |
|
|
2022
Q1 | $135M | Sell |
227,783
-18,131
| -7% | -$10.4M | 0.36% | 71 |
|
|
2021
Q4 | $164M | Buy |
245,914
+160,546
| +188% | +$100M | 0.37% | 69 |
|
|
2021
Q3 | $48.8M | Buy |
85,368
+22,593
| +36% | +$12.4M | 0.12% | 267 |
|
|
2021
Q2 | $31.7M | Sell |
62,775
-816
| -1% | -$385K | 0.08% | 342 |
|
|
2021
Q1 | $29M | Buy |
+63,591
| New | +$30.4M | 0.07% | 357 |
|
|
2020
Q2 | – | Sell |
-66,235
| Closed | -$18.8M | – | 697 |
|
|
2020
Q1 | $18.8M | Sell |
66,235
-54,716
| -45% | -$17.3M | 0.08% | 331 |
|
|
2019
Q4 | $39.3M | Sell |
120,951
-35,021
| -22% | -$10.6M | 0.13% | 245 |
|
|
2019
Q3 | $45.4M | Sell |
155,972
-15,884
| -9% | -$4.55M | 0.15% | 221 |
|
|
2019
Q2 | $50.5M | Sell |
171,856
-418
| -0.2% | -$115K | 0.16% | 219 |
|
|
2019
Q1 | $47.2M | Buy |
172,274
+148,474
| +624% | +$37M | 0.16% | 210 |
|
|
2018
Q4 | $5.33M | Buy |
+23,800
| New | +$5.58M | 0.02% | 642 |
|
|
2018
Q1 | – | Sell |
-174,740
| Closed | -$33.2M | – | 906 |
|
|
2017
Q4 | $33.2M | Sell |
174,740
-60,294
| -26% | -$11.6M | 0.09% | 334 |
|
|
2017
Q3 | $44.5M | Sell |
235,034
-186,367
| -44% | -$33.8M | 0.13% | 251 |
|
|
2017
Q2 | $73.5M | Sell |
421,401
-320
| -0.1% | -$53.8K | 0.22% | 135 |
|
|
2017
Q1 | $64.8M | Buy |
421,721
+394,100
| +1,427% | +$60.2M | 0.19% | 157 |
|
|
2016
Q4 | $3.9M | Sell |
27,621
-326,551
| -92% | -$48.1M | 0.01% | 777 |
|
|
2016
Q3 | $56.3M | Sell |
354,172
-150,511
| -30% | -$23.2M | 0.17% | 189 |
|
|
2016
Q2 | $74.6M | Sell |
504,683
-143,484
| -22% | -$21.2M | 0.23% | 120 |
|
|
2016
Q1 | $91.8M | Buy |
648,167
+624,167
| +2,601% | +$83.6M | 0.29% | 82 |
|
|
2015
Q4 | $3.4M | Sell |
24,000
-65,704
| -73% | -$8.76M | 0.01% | 796 |
|
|
2015
Q3 | $11M | Sell |
89,704
-362,861
| -80% | -$47.3M | 0.03% | 566 |
|
|
2015
Q2 | $58.7M | Buy |
452,565
+362,510
| +403% | +$47.3M | 0.15% | 202 |
|
|
2015
Q1 | $12.1M | Buy |
+90,055
| New | +$11.6M | 0.03% | 587 |
|
|
2014
Q4 | – | Sell |
-26,780
| Closed | -$3.26M | – | 980 |
|
|
2014
Q3 | $3.26M | Sell |
26,780
-1,189,083
| -98% | -$145M | 0.01% | 814 |
|
|
2014
Q2 | $143M | Sell |
1,215,863
-29,716
| -2% | -$3.5M | 0.33% | 80 |
|
|
2014
Q1 | $150M | Sell |
1,245,579
-455,999
| -27% | -$54.2M | 0.34% | 75 |
|
|
2013
Q4 | $189M | Sell |
1,701,578
-663,069
| -28% | -$65.9M | 0.42% | 38 |
|
|
2013
Q3 | $218M | Sell |
2,364,647
-258,590
| -10% | -$23.4M | 0.5% | 30 |
|
|
2013
Q2 | $222M | Buy |
+2,623,237
| New | +$218M | 0.51% | 27 |
|
Other funds holding TMO
VCM
Lord, Abbett & Co's TMO Position: Q1 2026 in Review
Lord, Abbett & Co reduced its Thermo Fisher Scientific (TMO) stake by 26% in Q1 2026, selling an estimated $1.68M and leaving 8,726 shares worth $4.29M. The position accounts for 0.01% of the portfolio, ranked #481.
Lord, Abbett & Co first reported a position in TMO in Q2 2013 and has held it in 44 quarters since. The position peaked at $222M in Q2 2013. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Lord, Abbett & Co held 8,726 shares of Thermo Fisher Scientific worth $4.29M as of Q1 2026.
- Lord, Abbett & Co sold 3,091 Thermo Fisher Scientific shares in Q1 2026, an estimated $1.68M.
- Thermo Fisher Scientific made up 0.01% of Lord, Abbett & Co's portfolio in Q1 2026, its #481 holding.
- Lord, Abbett & Co first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 44 quarters since.
- Lord, Abbett & Co's Thermo Fisher Scientific position peaked at $222M in Q2 2013.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Lord, Abbett & Co's 13F filing for Q1 2026, filed 14 May 2026.